Product Information

RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1706 per EA under NDC 65862065060. Its NADAC has been published 471 times since Nov 8, 2017.

FDA first approved this application on Mar 25, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVASTIGMINE 4.5 MG CAPSULE

Rivastigmine Tartrate
$0.1706per EA

Strength

4.5 mg/1

NDC

65862065060

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204572

FDA Approved

3/25/2016

TE Code

AB

On Market Since

3/25/2016

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 471 times since Nov 8, 2017, and over the history we have for it it has declined 82.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1706 per EA
All-time high$0.9662 (Nov 15, 2017)
All-time low$0.1706 (Oct 21, 2026)
52-week high$0.2100
52-week low$0.1706
Median price$0.2702
Average price$0.3214
Largest weekly change+103.3% (Jan 20, 2021)
Weeks tracked471
Tracking sinceNov 8, 2017

Price History

1W

0.0%

1M

-2.2%

3M

-8.8%

6M

-14.3%

1Y

-8.8%

3Y

-25.6%

5Y

-41.8%

All

-82.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1706 per EA (NDC 65862065060), effective Nov 11, 2026.

How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has declined 82.3%. It has been tracked across 471 weekly CMS publications since Nov 8, 2017.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?

Since Nov 8, 2017, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1706 (Oct 21, 2026) to a high of $0.9662 (Nov 15, 2017), with a median of $0.2702 per EA.

Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 4.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?

RIVASTIGMINE 4.5 MG CAPSULE (NDC 65862065060) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.